“…Ex vivo conjugate assays were performed by modifying our previously described conjugate assay (14, 15, 18, 21, 22), using splenic dendritic cells enriched from mice treated for 14 days with a B16 tumor expressing FLT3 ligand (33). Briefly, single cell suspensions obtained from spleens of FLT3 conditioned mice, which contained 25–35% CD11c + MHCII + dendritic cells, were labeled with Cell Tracker Orange (CTO, Thermo Fisher) as previously described (14, 15, 18, 21, 22) and then pulsed with the indicated doses of SIINFEKL peptide for 30 mins at 37C in warm TCPM, washed, and resuspended at 5 x 10 6 cells/ml in pre-warmed TCPM.…”